Skip to main content

Table 4 Serial analysis of marker expression in patients who had both pre- and post-operative specimens (by Wilcoxon signed rank test)

From: p21 and CD166 as predictive markers of poor response and outcome after fluorouracil-based chemoradiotherapy for the patients with rectal cancer

Markers

Mean score

P-value

 

Pre-operative specimen

Post-operative specimen

 

p53

7.098

6.845

0.135

Ki67

48.098

21.555

0.001

TS

1.126

1.291

0.661

BAX

4.357

4.943

0.326

HIF1α

1.563

0.591

0.001

ALDH1

1.197

3.507

0.001

CD166

0.478

2.305

0.001

p21

6.357

7.281

0.090

EpCAM

9.985

12.0

0.001

CD44

1.394

0.859

0.028

CD133

3.943

4.309

0.193

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us